The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pharmacokinetic study of aldoxorubicin in solid tumor patients.
Ronald B. Natale
No relevant relationships to disclose
Alain C. Mita
Research Funding - CytRx Corporation
Edward M. Wolin
No relevant relationships to disclose
Brenda Laabs
No relevant relationships to disclose
Hillary Dinh
Employment or Leadership Position - CytRx Corporation
Scott Wieland
Employment or Leadership Position - CytRx Corporation
Stock Ownership - CytRx Corporation
Daniel Levitt
Employment or Leadership Position - CytRx Corporation
Stock Ownership - CytRx Corporation
Monica M. Mita
Research Funding - CytRx Corporation